MedTrace Logo

Clinical Study to Evaluate the Body Fat Reducing Effect and Safety of GTB1

NCT06422013 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-05-22

No results posted yet for this study

Summary

This study was conducted to investigate the effects of daily supplementation of GTB1 on decrease of body fat.

Conditions

  • Body Fat

Interventions

DIETARY_SUPPLEMENT

GTB1

oral administration of GTB1 powder packet once daily

DIETARY_SUPPLEMENT

Placebo

oral administration of placebo powder packet once daily

Sponsors & Collaborators

  • Amorepacific Corporation

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-28
Primary Completion
2023-12-08
Completion
2023-12-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06422013 on ClinicalTrials.gov